Combination of hydralazine and all-trans retinoic acid targeting breast cancer cells

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2025-09-24
DOI
https://doi.org/10.1186/s12885-025-14477-2
Primary Topic
Retinoids in leukemia and cellular processes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combination of hydralazine and all-trans retinoic acid targeting breast cancer cells

Mohammad Mehdi Yaghoobi, Nahid Askari, amirhesan Yahyapour
BMC Cancer
Retinoids in leukemia and cellular processes
article

Combination of hydralazine and all-trans retinoic acid targeting breast cancer cells

Mohammad Mehdi Yaghoobi, Nahid Askari, amirhesan Yahyapour
article en

Abstract

No abstract available for this paper.
BMC CancerVol. 25(1)
Graduate University of Advanced Technology (IR)
Graduate University of Advanced Technology
Openalex Percentile: Top 77%
Retinoids in leukemia and cellular processes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Combination of hydralazine and all-trans retinoic acid targeting breast cancer cells — Mohammad Mehdi Yaghoobi, Nahid Askari, et al. · BMC Cancer (2025) | TGRS Research Map | TGRS